News
Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...
Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...
Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Q4 results handily beat expectations, but the real story was its cautious FY26 outlook, which sent shares lower in early ...
Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results